Past Events

Page Contents >



Modelling costs and outcomes for dementia: MODEM project launch
15th May 2014, 13:30 - 16:00
Venue: NAB LG.08, New Academic Building, London School of Economics

Dementia – considered one of the leading challenges for the country as the population ages – has been flagged as a high priority for government, the NHS and local councils. Evidence suggests that there are currently 670,000 people with dementia in England, with annual costs of £23 billion with the contribution of family carers being valued at £8 billion.

In December, the G8 countries held a Dementia Summit in London. The joint declaration from the eight Health Ministers included a commitment “to improve the quality of life for people with dementia and their carers while reducing emotional and financial burden.”

This event launched a new collaborative study funded by the Economic and Social Research Council and the National Institute for Health Research.

MODEM - Comprehensive approach to modelling outcome and cost impacts of interventions for dementia - will develop a comprehensive set of quantitative models to forecast how many people will develop dementia in England over the next 30 years; the unpaid support services available from family and other carers; and the projected costs of their treatment and care. It will be carried out in collaboration with researchers from the London School of Economics and Political Science, Newcastle University, the University of Southampton, University of Sussex and the International Longevity Centre-UK. It is one of six dementia projects being funded under a major new ESRC/NIHR programme.

Speakers included Professor Sube Banerjee (University of Sussex), Professor Carol Jagger (University of Newcastle), Professor Emily Grundy, Adelina Comas-Herrera, Professor Martin Knapp (London School of Economics and Political Science), Dr Doug Brown (Alzheimer’s Society) and Emily Holzhausen (Carers UK) among others.

Launch of the WHO Consultative Committee Report - Making Fair Choices on the Path to Universal Health Coverage
1st May 2014
Hosted by: LSE Health and Social Care and Department of Philosophy, Logic and Scientific Method
Venue: CLM.6.02, Clement House, Aldwych

Countries around the world are moving towards Universal Health Coverage. Along the way, they face difficult choices. The WHO Consultative Group on Equity and Universal Health Coverage has produced a report to offer guidance on how to make these choices fairly. This seminar presented the Group’s recommendations and offers reflection from leading academics and policy-makers in health policy.


School for Social Care Research (SSCR) Annual Conference
Date: 8th April 2014, 10am - 4:30pm
Venue: New Academic Building, London School of Economics

The School's Annual Conference provided an opportunity to hear about emerging evidence from SSCR’s commissioned studies and implications for adult social care practice. Further information can be found on the SSCR website|.


The LSE Summit: Risk Sharing and Managed Entry Agreements
14 February 2014, 9am-5pm
Venue: The Royal College of Surgeons, Lecture Theatre Two, 35-43 Lincoln's Inn Fields, London WC2A 3PE, UK
Speakers: Speakers are drawn from national competent authorities on pricing, reimbursement and HTA, pharmaceutical manufacturers, international organisations, patient representative organisations and academia

Uncertainty identified during health technology assessment of innovative new medicines is increasingly being addressed through a managed entry agreement / risk-sharing agreement between the manufacturer and the payer. Over time, there has been a proliferation of managed entry schemes focusing, among other things, on price, utilisation and outcomes.

The Medical Technology Research Group (MTRG) at LSE Health were delighted to organise and host a one-day summit on Risk Sharing and Managed Entry Agreements (MEAs) in February 2014. Speakers debated the latest developments and will also reflect on future prospects and policy options.

The summit was sponsored by Ernst and Young, with media partner The Financial Times.